Optum Rx is nixing reauthorization requirements for more than 60 additional medications. | The PBM giant's list of drugs ...

UnitedHealth stock outlook is in sharp focus as shares stay locked between $300 and $310. With Q2 earnings approaching and ...

UnitedHealth Group is making key leadership changes across its Optum health services business as Stephen Hemsley resumes his ...

Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company ...

UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.  The cuts are in addition to about 80 reauthorizations Optum Rx ...

The leader of UnitedHealth Group Inc.’s Optum Health care delivery unit has left the role, an early indication of management ...

UnitedHealth Group (UNH) stock gains marginally as the company names a new CEO for its health services division, Optum Health ...

UnitedHealth Group subsidiary Optum is launching AI Marketplace, a healthcare-specific artificial intelligence platform ...

Optum CEO Patrick Conway, M.D., will be playing double duty as UnitedHealth Group has named him chief executive of its Optum Health unit, a spokesperson confirmed. | Optum CEO Patrick Conway will be ...

Optum Rx officials said they now have eliminated reauthorization requirements for more than 140 chronic disease medications.

Public-private partnerships will be essential to expanding access to community health services in New York and New Jersey.